Last reviewed · How we verify
NCT07286552
Breathing Pattern Description in Pneumonia Patients
trial testing Temperature sensors located in the Venturi mask, placed around the nose and mouth in Acute Respiratory Failure (ARF) in 82 participants. Participants enrolled and being followed up; not accepting new ones.
28 February 2024
Quick facts
| Lead sponsor | Consorci Sanitari Integral |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 82 |
| Start date | 24 November 2022 |
| Primary completion | 28 February 2024 |
| Estimated completion | 20 December 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Temperature sensors located in the Venturi mask, placed around the nose and mouth
Conditions studied
- Acute Respiratory Failure (ARF) — all drugs for Acute Respiratory Failure (ARF) →
Sponsor
Consorci Sanitari Integral — full company profile →
Who can join
18 and older, any sex, with Acute Respiratory Failure (ARF). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Surveillance and monitoring of patients with respiratory failure before or after undergoing mechanical ventilation is an underdeveloped area compared to the many possibilities of monitoring other non-invasive vital signs that we currently have. Severe respiratory failure usually affects oxygenation and ventilation. Continuous or frequent non-invasive monitoring of oxygenation is performed with pulse oximetry, with a margin of error between 1 and 4% of arterial oxygen saturation of hemoglobin. Ventilation cannot be fully monitored in non-intubated patients: Measurement of respiratory rate (RR) outside the Intensive Care Unit (ICU) is usually performed intermittently and manually by the nurse, often with a wide margin of error and, regarding tidal volume (VT), it cannot currently be monitored either directly or indirectly in non-intubated patients because the measurement itself interferes with respiration. Similarly, data on inspiratory and expiratory flows cannot be obtained, which are also altered in certain pathologies. The technique considered as a "gold standard" is spirometry, which requires the collaboration of the patient, and the interpretation of the results depends on the performance of the technique in a standardized way. Spirometry offers a single value; continuous monitoring is not feasible and due to the bias of the technique. More studies are needed to rule out the existence of different breathing patterns of acute respiratory failure and to identify outcome differences between them before recommending different support or treatment approaches. In a preliminary not published study conducted with healthy volunteers, a good correlation was observed between changes in temperature inside the Venturi mask using two TSC50 thermistors and breathing pattern recorded by thoracic and abdominal plethysmographic bands. HYPOTHESES: Monitoring respiratory activity, including both RR and the respiratory pattern (tidal volume, inspiratory flow, and the inspiration-to-expiration ratio), could enable early detection of respiratory patterns associated with the worsening of patients with COVID-19 pneumonia and severe pneumonia of other origins. OBJECTIVES Main Objective: To evaluate the ability of the respiratory pattern to early detect respiratory deterioration in patients hospitalized pneumonia before requiring mechanical ventilation. Specific Objectives: To describe the initial respiratory pattern and its evolution throughout the hospital stay of patients with acute respiratory failure caused by SARS-CoV-2. To describe the evolution of the respiratory pattern in patients with bacterial pneumonia admitted to the hospital who require supplemental oxygen.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07286552
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Respiratory Failure (ARF)
Currently open trials in the same condition.
- NCT07379242 — Lung Recruitment Assessed by 2D/3D-EIT and R/I Ratio in Acute Respiratory Failure Patients With Mechanical Ventilation · recruiting
- NCT06848218 — Music Therapy During NIV Implantation in Pediatric Intensive Care Units · NA · recruiting
- NCT05689476 — Electrical Activity of the Diaphragm and Respiratory Mechanics During NAVA · NA · recruiting
- NCT07265882 — Bed Side Assessment in Patients With Acute Respiratory Failure Under Invasive Mechanical Ventilation · recruiting
Other Consorci Sanitari Integral trials
Trials by the same sponsor.
- NCT06993220 — Evaluating Residual Congestion at Discharge in Acute Heart Failure Patients · recruiting
- NCT06533839 — Prevention of Parastomal Hernias With a Preformed Three-dimensional, Funnel-shaped Mesh · NA · not yet recruiting
- NCT05815914 — Nutritional Support and Telemedicine · NA · unknown
- NCT04037449 — Transversus Abdominis Plane Block in the Analgesia of Acute Pancreatitis · NA · unknown
- NCT04625712 — Election of the Optimal Moment of Colecistectomy After Mild Biliary Pancreatitis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07286552 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Consorci Sanitari Integral
- Last refreshed: 16 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07286552.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing